EU decision-making for marketing authorization of advanced therapy medicinal products: a case study

Sofieke de Wilde; Delphi G. M. Coppens; Jarno Hoekman; Marie L. de Bruin; Hubert G. M. Leufkens; Henk-Jan Guchelaar; Pauline Meij

doi:10.1016/j.drudis.2018.03.008

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study

Sofieke de Wilde, Delphi G. M. Coppens, Jarno Hoekman, Marie L. de Bruin, Hubert G. M. Leufkens, Henk-Jan Guchelaar, Pauline Meij

Original language	English
Journal	Drug Discovery Today
Volume	23
Issue number	7
Pages (from-to)	1328-1333
ISSN	1359-6446
DOIs	https://doi.org/10.1016/j.drudis.2018.03.008
Publication status	Published - Jul 2018

Access to Document

10.1016/j.drudis.2018.03.008Licence: CC BY-NC-ND

decision.pdfFinal published version, 262 KBLicence: CC BY-NC-ND

Cite this

@article{9725091fc99e487093854b882a6702ba,

title = "EU decision-making for marketing authorization of advanced therapy medicinal products: a case study",

author = "{de Wilde}, Sofieke and Coppens, {Delphi G. M.} and Jarno Hoekman and {de Bruin}, {Marie L.} and Leufkens, {Hubert G. M.} and Henk-Jan Guchelaar and Pauline Meij",

year = "2018",

month = jul,

doi = "10.1016/j.drudis.2018.03.008",

language = "English",

volume = "23",

pages = "1328--1333",

journal = "Drug Discovery Today: BIOSILICO",

issn = "1359-6446",

publisher = "Elsevier Ltd. * Trends Journals",

number = "7",

}

TY - JOUR

T1 - EU decision-making for marketing authorization of advanced therapy medicinal products: a case study

AU - de Wilde, Sofieke

AU - Coppens, Delphi G. M.

AU - Hoekman, Jarno

AU - de Bruin, Marie L.

AU - Leufkens, Hubert G. M.

AU - Guchelaar, Henk-Jan

AU - Meij, Pauline

PY - 2018/7

Y1 - 2018/7

U2 - 10.1016/j.drudis.2018.03.008

DO - 10.1016/j.drudis.2018.03.008

M3 - Review

C2 - 29574211

SN - 1359-6446

VL - 23

SP - 1328

EP - 1333

JO - Drug Discovery Today: BIOSILICO

JF - Drug Discovery Today: BIOSILICO

IS - 7

ER -

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study

Access to Document

Fingerprint

Cite this